Therapeutic Effects of a Long-Acting Cholinergic Receptor Blocker, Tiotropium Bromide, on Asthma.
CONCLUSIONS Tiotropium bromide combined with fluticasone propionate improved the respiratory function and quality of life, and is a new therapy for moderate, persistent asthma.
PMID: 29446377 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Advair | Advair Diskus | Asthma | Biomedical Science | Flonase | Flovent | Pulmonary Function Testing | Research | Respiratory Medicine | Science | Spiriva | Study | Tiotropium